|
|
||||||||



*
Department of Pediatrics, University of Washington, Seattle, WA 98195;
Department of Medicine III, Osaka University Medical School, Osaka, Japan;
Department of Pediatrics, Toyama Medical and Pharmaceutical University, Toyama, Japan; and
§
Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan
X-linked agammaglobulinemia (XLA) is a primary
immunodeficiency disease caused by mutations of Bruton tyrosine kinase
(Btk); Btk plays an essential role in the development of mature B
cells. However, small numbers of B cells ("leaky B cells")
are present in the peripheral blood of most XLA patients. In this
study, we analyzed the function of these leaky B cells obtained from
XLA patients. Enough numbers of B cells were available for analysis
from five of nine XLA patients originally screened. Sequence analysis
revealed missense mutations of Btk in four of the five
XLA patients. No mutation was found in the coding region of
Btk in one patient. Western blotting and/or flow
cytometric analysis failed to detect Btk protein in all five patients.
B cells isolated from peripheral blood of these XLA patients were
CD5-, CD20+, CD19+, and
CD21-. If stimulated with anti-CD40 and IL-4, XLA B
cells proliferated normally and produced significant amounts of IgE.
Anti-CD40 stimulation of XLA B cells resulted in normal expression of
CD23. In addition, three of the five XLA patients studied were
immunized with bacteriophage
X174 and produced low but
detectable levels of antiphage-specific Ab. Similarly, X-linked
immunodeficiency mice, which carry a missense mutation in
Btk, produced substantial amounts of antiphage Ab. These
results indicate that CD40 signaling is intact in B cells lacking
demonstrable Btk, and that leaky B cells in XLA patients can
proliferate, undergo isotype switching, and differentiate into specific
Ab-producing cells.
This article has been cited by other articles:
![]() |
S. A. Haxhinasto and G. A. Bishop Synergistic B Cell Activation by CD40 and the B Cell Antigen Receptor: ROLE OF B LYMPHOCYTE ANTIGEN RECEPTOR-MEDIATED KINASE ACTIVATION AND TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR REGULATION J. Biol. Chem., January 23, 2004; 279(4): 2575 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Tumang, R. S. Negm, L. A. Solt, T. J. Schneider, T. P. Colarusso, W. D. Hastings, R. T. Woodland, and T. L. Rothstein BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton's Tyrosine Kinase J. Immunol., March 15, 2002; 168(6): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
C G Vinuesa, C de Lucas, and M C Cook Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens Postgrad. Med. J., September 1, 2001; 77(911): 562 - 569. [Full Text] [PDF] |
||||
![]() |
K. Nomura, H. Kanegane, H. Karasuyama, S. Tsukada, K. Agematsu, G. Murakami, S. Sakazume, M. Sako, R. Tanaka, Y. Kuniya, et al. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway Blood, July 15, 2000; 96(2): 610 - 617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |